In fact, S233 phosphorylation of LIMD1 has been identified by high throughput profiling assays in many other cancers, including breast and ovarian cancers and pancreatic ductal adenocarcinoma, with or without stresses (36–38). This evidence concerns the gene LIMD1 and pancreatic ductal adenocarcinoma.